Advertisement

Topics

ANI Pharmaceuticals, Inc. Bottom Line Climbs 32% In Q2

09:19 EDT 3 Aug 2017 | FinanzNachrichten

WASHINGTON (dpa-AFX) - ANI Pharmaceuticals, Inc. (ANIP) revealed earnings for its second quarter that advanced compared to the same period last year.The company said its bottom line advanced to $1...

Original Article: ANI Pharmaceuticals, Inc. Bottom Line Climbs 32% In Q2

NEXT ARTICLE

More From BioPortfolio on "ANI Pharmaceuticals, Inc. Bottom Line Climbs 32% In Q2"

Quick Search
Advertisement